Catatan efek · kuartal yang diarsipkan
AZN
AstraZeneca PLC · Healthcare · Drug Manufacturers - General
22Pemegang yang dilacak
-1Δ pemegang
189.68MSaham yang dipegang
$13.26BNilai yang dilaporkan
+0Posisi baru
−1Keluar
Input momentum (manajer yang sebanding):
keluasan pemegang -4.3% ·
aliran saham -4.1% ·
posisi baru bersih -4.5%
— formula
Distribusi luas — penurunan saham dan lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2025
Kepemilikan dari waktu ke waktu
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 156 | +6 | 601.54M | $113.17B | +11 | −4 |
| Q1 2026 | 151 | +2 | 571.10M | $111.81B | +21 | −20 |
| Q4 2025 | 148 | 0 | 438.95M | $40.35B | +2 | −1 |
| Q3 2025 | 24 | 0 | 219.30M | $16.82B | +1 | −2 |
| Q2 2025 | 22 | -1 | 189.68M | $13.26B | — | −1 |
| Q1 2025 | 21 | 0 | 171.06M | $12.57B | — | — |
| Q4 2024 | 21 | +3 | 174.28M | $11.42B | +3 | — |
| Q3 2024 | 17 | -3 | 166.39M | $12.97B | — | −3 |
| Q2 2024 | 20 | — | 172.48M | $13.45B | — | — |
Siapa yang memegangnya · Q2 2025
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 51.94M | -9.0% | $3.63B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 51.94M | -9.0% | $3.63B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 3 | PRIMECAP Management ✦ | 41.20M | +1.3% | $2.88B | 2.3% | ▲ Add | 5 | SEC ↗ |
| 4 | Wellington Management ✦ | 34.34M | -3.6% | $2.40B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 5 | Wellington Management ✦ | 34.34M | -3.6% | $2.40B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 6 | Wellington Management ✦ | 34.34M | -3.6% | $2.40B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 7 | Wellington Management ✦ | 34.34M | -3.6% | $2.40B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 8 | Wellington Management ✦ | 34.34M | -3.6% | $2.40B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 9 | Wellington Management ✦ | 34.34M | -3.6% | $2.40B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 10 | Wellington Management ✦ | 34.34M | -3.6% | $2.40B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 11 | Wellington Management ✦ | 34.34M | -3.6% | $2.40B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 12 | Fidelity (FMR) ✦ | 21.34M | — | $1.49B | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 21.34M | — | $1.49B | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 21.34M | — | $1.49B | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 21.34M | — | $1.49B | 0.1% | n/c | 1 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 21.34M | — | $1.49B | 0.1% | n/c | 1 | SEC ↗ |
| 17 | Fidelity (FMR) ✦ | 21.34M | — | $1.49B | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 20.70M | +2.6% | $1.45B | 0.6% | ▲ Add | 5 | SEC ↗ |
| 19 | BlackRock ✦ (pasif) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (pasif) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (pasif) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (pasif) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (pasif) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | BlackRock ✦ (pasif) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | BlackRock ✦ (pasif) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | BlackRock ✦ (pasif) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | BlackRock ✦ (pasif) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | BlackRock ✦ (pasif) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | BlackRock ✦ (pasif) | 5.49M | — | $383.47M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Marshall Wace ✦ | 2.00M | +45.3% | $139.76M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 31 | Marshall Wace ✦ | 2.00M | +45.3% | $139.76M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 32 | D. E. Shaw & Co. ✦ | 1.90M | +12.2% | $133.12M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 33 | D. E. Shaw & Co. ✦ | 1.90M | +12.2% | $133.12M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 34 | Citadel Advisors ✦ | 1.83M | -10.5% | $127.95M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 35 | Citadel Advisors ✦ | 1.83M | -10.5% | $127.95M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 36 | Point72 Asset Management ✦ | 1.69M | +41.9% | $117.79M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 37 | Renaissance Technologies ✦ | 1.30M | +335.8% | $91.11M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 38 | Arrowstreet Capital ✦ | 1.16M | -67.8% | $80.75M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 39 | Millennium Management ✦ | 1.14M | +20.3% | $79.97M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 40 | State Street Global Advisors ✦ (pasif) | 939.00K | -6.0% | $65.62M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 41 | Two Sigma Investments ✦ | 858.50K | +88.9% | $59.99M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 42 | Bridgewater Associates ✦ | 620.90K | -10.2% | $43.39M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 43 | Geode Capital Management ✦ (pasif) | 505.06K | +2.9% | $35.29M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 44 | Adage Capital Partners ✦ | 325.39K | -49.7% | $22.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 45 | Capital World Investors ✦ | 153.56K | +2.8% | $10.73M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 46 | Dodge & Cox ✦ | 137.49K | +1.0% | $9.61M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 47 | Norges Bank ✦ (pasif) | 60.38K | +268.6% | $4.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 48 | AQR Capital Management ✦ | 53.94K | +43.9% | $3.77M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 53.94K | +43.9% | $3.77M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 50 | AQR Capital Management ✦ | 53.94K | +43.9% | $3.77M | 0.0% | ▲ Add | 5 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Soros Fund Management | $201.57M | adalah 5.1% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 2 pemegang, 42.58K saham, $8.26M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Sering dimiliki bersama
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Asal-usul data: Kepemilikan dari posisi saham biasa 13F yang telah diurai (semesta yang dipantau, set pembanding untuk perubahan); baris orang dalam dari Formulir 3/4/5; kepemilikan saham signifikan dari Jadwal 13D/13G; setiap pengajuan tertaut ke dokumen aslinya di SEC EDGAR.
Periode pelaporan: Q2 2025 ·
Metodologi ·
Dapatkan ini melalui API